BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-0.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.89B
AUM Growth
+$6.89B
(-8.5%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
178
New
7
Increased
49
Reduced
68
Closed
19
Top Buys
| 1 |
Medtronic
MDT
|
$49.2M |
| 2 |
Align Technology
ALGN
|
$30.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$15.6M |
| 4 |
Veeva Systems
VEEV
|
$14.1M |
| 5 |
Legend Biotech
LEGN
|
$7.35M |
Top Sells
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$159M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$27.3M |
| 3 |
DexCom
DXCM
|
$27.1M |
| 4 |
Cigna
CI
|
$26.9M |
| 5 |
Elevance Health
ELV
|
$26M |
Sector Composition
| 1 | Healthcare | 99.07% |
| 2 | Industrials | 0.84% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Castle Biosciences
CSTL
$673M
| $21.6M | 0.31% |
948,878
+4,566
| +0.5% | +$104K |
|
77
ResMed
RMD
$39.4B
| $21.5M | 0.31% |
98,275
| – | – |
|
78
Beam Therapeutics
BEAM
$1.9B
| $21.3M | 0.31% |
695,421
-1,300
| -0.2% | -$39.8K |
|
79
Procept Biorobotics
PRCT
$2.11B
| $21.1M | 0.31% |
741,517
| – | – |
|
80
Phreesia
PHR
$1.81B
| $20.6M | 0.3% |
638,653
-27,766
| -4% | -$897K |
|
81
Harmony Biosciences
HRMY
$2.16B
| $19.5M | 0.28% |
598,046
+1,854
| +0.3% | +$60.5K |
|
82
Wave Life Sciences
WVE
$1.27B
| $19.5M | 0.28% |
4,494,458
| – | – |
|
83
10x Genomics
TXG
$1.66B
| $18.1M | 0.26% |
324,746
| – | – |
|
84
Mersana Therapeutics
MRSN
$34.8M
| $17.7M | 0.26% |
4,299,619
+17,019
| +0.4% | +$70K |
|
85
Scholar Rock
SRRK
$3.3B
| $17.1M | 0.25% |
2,140,025
-12,000
| -0.6% | -$96K |
|
86
Generation Bio
GBIO
$40.3M
| $15.6M | 0.23% |
3,620,280
-7,000
| -0.2% | -$30.1K |
|
87
Doximity
DOCS
$12.6B
| $14.5M | 0.21% |
448,579
| – | – |
|
|
88
Cigna
CI
$80.2B
| $13.7M | 0.2% |
53,476
-105,145
| -66% | -$26.9M |
|
89
Natera
NTRA
$23B
| $12.9M | 0.19% |
232,775
+58,963
| +34% | +$3.27M |
|
90
Regeneron Pharmaceuticals
REGN
$59.8B
| $12.6M | 0.18% |
15,316
-362
| -2% | -$297K |
|
|
ONC
91
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $12.6M | 0.18% |
58,235
+23,735
| +69% | +$5.12M |
|
92
Teladoc Health
TDOC
$1.37B
| $11.2M | 0.16% |
432,721
+42,435
| +11% | +$1.1M |
|
93
Baxter International
BAX
$12.1B
| $11.1M | 0.16% |
273,614
-47,067
| -15% | -$1.91M |
|
94
Black Diamond Therapeutics
BDTX
$164M
| $10.2M | 0.15% |
5,395,839
-5,000
| -0.1% | -$9.45K |
|
95
Amgen
AMGN
$153B
| $9.28M | 0.13% |
38,367
-572
| -1% | -$138K |
|
96
Gilead Sciences
GILD
$140B
| $8.33M | 0.12% |
100,356
-29,987
| -23% | -$2.49M |
|
|
NVRO
97
DELISTED
NEVRO CORP.
NVRO
| $7.9M | 0.11% |
218,573
-42,262
| -16% | -$1.53M |
|
98
Biogen
BIIB
$20.8B
| $6.87M | 0.1% |
24,704
-3,700
| -13% | -$1.03M |
|
99
Esperion Therapeutics
ESPR
$490M
| $6.69M | 0.1% |
4,208,264
-122,000
| -3% | -$194K |
|
100
Dr. Reddy's Laboratories
RDY
$11.8B
| $5.89M | 0.09% |
103,500
-22,000
| -18% | -$1.25M |
|